I agree that this site is using cookies. You can find further informations here.
X
Vitte, Jeremie
49  results:
Search for persons X
?
1

Imaging as an early biomarker to predict sensitivity to eve..:

Nghiemphu, Phioanh Leia ; Vitte, Jeremie ; Dombi, Eva...
Journal of Neuro-Oncology.  167 (2024)  2 - p. 339-348 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Gene-targeted therapy for neurofibromatosis and schwannomat..:

Staedtke, Verena ; Anstett, Kara ; Bedwell, David...
Clinical Trials.  , 2023
Link: https://doi.org/10.1177/..
 
?
3

Cellular mechanisms of heterogeneity in NF2-mutant schwanno..:

Chiasson-MacKenzie, Christine ; Vitte, Jeremie ; Liu, Ching-Hui...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

RBIO-11. BASAL BCL-2-INTERACTING MEDIATOR OF CELL DEATH (BI..:

Harary, Maya ; Fernandez, Elizabeth ; Casaos, Joshua...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v258-v258 , 2023
Link: https://doi.org/10.1093/..
 
?
5

EXTH-87. DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TA..:

Sun, Matthew ; Orpilla, Joey ; Contreras, Erick...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii229-vii229 , 2022
Link: https://doi.org/10.1093/..
 
?
6

MODL-13. GENETICALLY ENGINEERED PIG MODEL OF RHABDOID TUMOR..:

Na, Brian ; Rubinstein, C Dustin ; Meudt, Jennifer J...
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii413-iii413 , 2020
Link: https://doi.org/10.1093/..
 
?
7

TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGIN..:

Osum, Sara ; Stemmer-Rachamimov, Anat ; Widemann, Brigitte...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi267-vi267 , 2019
Link: https://doi.org/10.1093/..
 
?
8

TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CRE..:

Vitte, Jeremie ; Gao, Fuying ; Coppola, Giovanni..
Neuro-Oncology.  21 (2019)  Supplement_2 - p. ii124-ii124 , 2019
Link: https://doi.org/10.1093/..
 
?
9

Preclinical assessment of MEK1/2 inhibitors for neurofibrom..:

Fuse, Marisa A ; Dinh, Christine T ; Vitte, Jeremie...
Neuro-Oncology.  21 (2019)  4 - p. 486-497 , 2019
Link: https://doi.org/10.1093/..
 
?
10

Genetically engineered minipigs model the major clinical fe..:

Isakson, Sara H. ; Rizzardi, Anthony E. ; Coutts, Alexander W....
Communications Biology.  1 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
11

Double somatic SMARCB1 and NF2 mutations in sporadic spinal..:

Paganini, Irene ; Capone, Gabriele Lorenzo ; Vitte, Jeremie...
Journal of Neuro-Oncology.  137 (2017)  1 - p. 33-38 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Timing of Smarcb1 and Nf2 inactivation determines schwannom..:

Vitte, Jeremie ; Gao, Fuying ; Coppola, Giovanni..
Nature Communications.  8 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
13

An allograft mouse model for the study of hearing loss seco..:

Bonne, Nicolas-Xavier ; Vitte, Jérémie ; Chareyre, Fabrice...
Journal of Neuro-Oncology.  129 (2016)  1 - p. 47-56 , 2016
Link: https://doi.org/10.1007/..
 
?
14

Conditional Inactivation of SMARCB1 in P0 Permissive Mouse ..:

Vitte, Jeremie ; Chareyre, Fabrice ; Stemmer-Rachamimov, Anat..
Cancer Genetics.  207 (2014)  9 - p. 451 , 2014
Link: https://doi.org/10.1016/..
 
?
15

mTORC1 inhibition delays growth of neurofibromatosis type 2..:

Giovannini, Marco ; Bonne, Nicolas-Xavier ; Vitte, Jeremie...
Neuro-Oncology.  16 (2014)  4 - p. 493-504 , 2014
Link: https://doi.org/10.1093/..
 
1-15